Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_01094 |
| Species: | Homo sapiens |
| Position : | chr17:38081807-38083807 |
| Year: | 2020 |
| Title: | CRISPRi-mediated functional analysis of lung disease-associated loci at non-coding regions. |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | asthma |
| PMID: | 32500120 |
| MONDO: | MONDO:0004979 |
| Tissue: | lung |
| Tissue Ontology ID: | UBERON:0002048 |
| Cell Source: | A-549 |
| CVCL ID: | CVCL_0023 |
| Cell Type: | epithelial cell of lung |
| Cell Ontology ID: | CL:0000082 |
| Experiment Type: | Enhancer activity assay; Functional perturbation assay; Gene expression assay; Endogenous enhancer perturbation; Chromatin interaction assay; Chromatin-state profiling; Disease-variant functional analysis |
| High Throughput Method: | Hi-C; ChIP-seq; eQTL analysis; GWAS |
| Low Throughput Method: | CRISPRi; RT-qPCR; ChIP |
| Target gene : | GSDMB |
| TF name : | NA |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|